Importance Anxiety disorders have a lifetime prevalence of approximately 34% in the US,
are often chronic, and significantly impair quality of life and functioning. Observations …

To date, the precise prevalence of co-morbidity of anxiety and depression in the perinatal
period is not well known. We aimed to estimate the prevalence of co-morbid anxiety and …

Background Anxiety disorders are a major cause of burden of disease. Treatment gaps have
been described, but a worldwide evaluation is lacking. We estimated, among individuals …

" The Practice of Electroconvulsive Therapy, Third Edition, provides a comprehensive yet
practical overview of the safe and effective use of ECT, with recommendations applicable …

Background The Patient Health Questionnaire-4 (PHQ-4) is an ultra-brief instrument that
measures depressive and anxiety symptoms. Although it has been frequently used in the …

Background Taking a broad approach, the aim of this study was to better understand
severity and prevalence of various types of mental ill-health across age and sex groups in …

Background We evaluated the validity and reliability of multiple symptom scales for
depression and anxiety for persons with inflammatory bowel disease (IBD). Methods IBD …

Background The prevalence of comorbid anxiety and depressive disorders is high among
patients with chronic diseases in primary care, and is associated with increased morbidity …

Abstract Background The Patient Health Questionnaire-4 (PHQ-4) is an ultra-brief self-report
consisting of a 2-item depression scale (PHQ-2) and a 2-item anxiety scale (GAD-2). The …

Background Emotional disorders are common, and they have become more prevalent since
the COVID-19 pandemic. Due to a high attendance burden at the specialized level, most …